| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.83M | $87.90M | - | |
| Dir | 1.55M | $74.81M | - | |
| Dir | 1.19M | $57.27M | - | |
| CFO | 1.08M | $51.86M | - | |
| VP | 733.1K | $35.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | Poste George | Director | Sale+OE | 20,634 | $45.99 | $948,957.66 | -10.9% | -15.3% | - | |
| May 16, 2025 | Senner Christopher J. | EVP And CFO | Sale+OE | 100,000 | $46.00 | $4,600,000.00 | -9.4% | -15.3% | - | |
| May 16, 2025 | Peterson Amy C. | EVP Prod Dev &Med Aff &CMO | Sale+OE | 72,776 | $45.47 | $3,309,124.72 | -13.5% | -15.3% | - | |
| May 15, 2025 | Hessekiel Jeffrey54 | EVP &General Counsel | Sell | 25,000 | $46.18 | $1,154,500.00 | -3.5% | -16.8% | - | |
| May 15, 2025 | Papadopoulos Stelios56 | Director | Sale+OE | 36,508 | $44.35 | $1,619,129.80 | -1.4% | -16.8% | - | |
| May 15, 2025 | Haley Patrick J.57 | EVP, Commercial | Sale+OE | 136,383 | $47.58 | $6,488,503.15 | -9.0% | -16.8% | - | |
| May 1, 2025 | Aftab Dana | Cso/ EVP Disc &Trans Research | Sell | 1,508 | $39.00 | $58,812.00 | -0.2% | -5.2% | +12.3% | |
| Mar 3, 2025 | Haley Patrick J.57 | EVP, Commercial | Sell | 10,000 | $38.80 | $388,000.00 | -2.8% | +11.2% | +5.7% | |
| Feb 28, 2025 | Wyszomierski Jack L | Director | Sale+OE | 8,768 | $37.80 | $331,430.40 | -2.4% | +10.1% | +13.9% | |
| Feb 28, 2025 | Smith Julie | Director | Sale+OE | 73,808 | $38.00 | $2,804,459.10 | -77.4% | +10.1% | +13.9% |